Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Jazz Pharmaceuticals (JAZZ)

Jazz Pharmaceuticals PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:JAZZ
DateTimeSourceHeadlineSymbolCompany
16/09/202412:30PR Newswire (US)Jazz Pharmaceuticals Presents Updated Phase 2 Data for Zanidatamab Demonstrating Increased mPFS in HER2-Positive Metastatic Gastroesophageal Adenocarcinoma at ESMO 2024NASDAQ:JAZZJazz Pharmaceuticals PLC
11/09/202416:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
09/09/202412:58PR Newswire (US)Jazz Pharmaceuticals to Present Advancements in Solid Tumor Oncology Research at ESMO 2024NASDAQ:JAZZJazz Pharmaceuticals PLC
06/09/202421:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:JAZZJazz Pharmaceuticals PLC
06/09/202400:50Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
05/09/202412:30PR Newswire (US)Jazz Pharmaceuticals to Present New Data Demonstrating Improved Epilepsy Outcomes with Epidiolex®/Epidyolex® (cannabidiol) at the European Epilepsy Congress 2024NASDAQ:JAZZJazz Pharmaceuticals PLC
04/09/202405:12PR Newswire (US)Jazz Pharmaceuticals Announces Pricing of Private Offering of $850 Million of 3.125% Exchangeable Senior Notes due 2030 and Concurrent Ordinary Share RepurchasesNASDAQ:JAZZJazz Pharmaceuticals PLC
04/09/202405:00PR Newswire (US)Jazz Pharmaceuticals Announces Pricing of Private Offering of $850 Million of 3.125% Exchangeable Senior Notes due 2030 and Concurrent Ordinary Share RepurchasesNASDAQ:JAZZJazz Pharmaceuticals PLC
03/09/202412:00PR Newswire (US)Jazz Pharmaceuticals Announces Private Offering of $850 Million of Exchangeable Senior Notes due 2030 and Concurrent Ordinary Share RepurchasesNASDAQ:JAZZJazz Pharmaceuticals PLC
28/08/202419:27Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:JAZZJazz Pharmaceuticals PLC
22/08/202421:05PR Newswire (US)Jazz Pharmaceuticals Provides Update on Cannabidiol Oral Solution Phase 3 Trial in Japan in Treatment-Resistant EpilepsiesNASDAQ:JAZZJazz Pharmaceuticals PLC
21/08/202421:15PR Newswire (US)Jazz Pharmaceuticals to Participate in Upcoming September Investor ConferencesNASDAQ:JAZZJazz Pharmaceuticals PLC
21/08/202421:15PR Newswire (US)Jazz Pharmaceuticals to Participate in Upcoming September Investor ConferencesNASDAQ:JAZZJazz Pharmaceuticals PLC
06/08/202423:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
06/08/202423:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
06/08/202423:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
06/08/202423:40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
06/08/202423:40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
06/08/202423:39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
06/08/202423:39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
06/08/202421:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
06/08/202421:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
06/08/202421:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
06/08/202421:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
06/08/202402:57Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
06/08/202402:55Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
06/08/202402:42Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
06/08/202402:35Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
06/08/202402:29Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
06/08/202402:19Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
 Showing the most relevant articles for your search:NASDAQ:JAZZ